Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Severe aortic stenosis management in heart valve centres compared with primary/secondary care centres

TK. Rudolph, D. Messika-Zeitoun, N. Frey, M. Lutz, L. Krapf, S. Passefort, J. Fryearson, H. Simpson, K. Mortensen, S. Rehse, A. Tiroke, F. Dodos, F. Mies, C. Deutsch, J. Kurucova, M. Thoenes, P. Bramlage, RP. Steeds, IMPULSE enhanced investigators

. 2023 ; 109 (12) : 944-950. [pub] 20230526

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011374
E-zdroje Online Plný text

NLK ProQuest Central od 1996-01-01 do Před 3 měsíci
Health & Medicine (ProQuest) od 1996-01-01 do Před 3 měsíci

Odkazy

PubMed 36657962
DOI 10.1136/heartjnl-2022-321566
Knihovny.cz E-zdroje

OBJECTIVE: Current guidelines recommend use of heart valve centres (HVCs) to deliver optimal quality of care for patients with valve disease but there is no evidence to support this. The hypothesis of this study is that patient care with severe aortic stenosis (AS) will differ in HVCs compared with satellite centres. We aimed to compare the treatment of patients with AS at HVCs (tertiary care hospitals with full access to AS interventions) to satellites (hospitals without such access). METHODS: IMPULSE enhanced is a European, observational, prospective registry enrolling consecutive patients with newly diagnosed severe AS at four HVCs and 10 satellites. Clinical characteristics, interventions performed and outcomes up to 1 year by site-type were examined. RESULTS: Among 790 patients, 594 were recruited in HVCs and 196 in satellites. At baseline, patients in HVCs had more severe valve disease (higher peak aortic velocity (4.3 vs 4.1 m/s; p=0.008)) and greater comorbidity (coronary artery disease (CAD) (44% vs 27%; p<0.001) prior myocardial infarction (MI) (11% vs 5.1%; p=0.011) and chronic pulmonary disease (17% vs 8.9%; p=0.007)) than those presenting in satellites. An aortic valve replacement was performed more often by month 3 in HVCs than satellites in the overall population (52.6% of vs 31.3%; p<0.001) and in symptomatic patients (66.7% vs 43.2%, p<0.001). One-year survival rate was higher for patients in HVCs than satellites (HR2.19; 95% CI 1.28 to 3.73 total population and 2.89 (95%CI 1.64 to 5.11) for symptomatic patients. CONCLUSIONS: Our data support the implementation of referral pathways that direct patients to HVCs performing both surgery and transcatheter interventions. TRIAL REGISTRATION NUMBER: NCT03112629.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011374
003      
CZ-PrNML
005      
20230801133016.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/heartjnl-2022-321566 $2 doi
035    __
$a (PubMed)36657962
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Rudolph, Tanja K $u Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, Germany
245    10
$a Severe aortic stenosis management in heart valve centres compared with primary/secondary care centres / $c TK. Rudolph, D. Messika-Zeitoun, N. Frey, M. Lutz, L. Krapf, S. Passefort, J. Fryearson, H. Simpson, K. Mortensen, S. Rehse, A. Tiroke, F. Dodos, F. Mies, C. Deutsch, J. Kurucova, M. Thoenes, P. Bramlage, RP. Steeds, IMPULSE enhanced investigators
520    9_
$a OBJECTIVE: Current guidelines recommend use of heart valve centres (HVCs) to deliver optimal quality of care for patients with valve disease but there is no evidence to support this. The hypothesis of this study is that patient care with severe aortic stenosis (AS) will differ in HVCs compared with satellite centres. We aimed to compare the treatment of patients with AS at HVCs (tertiary care hospitals with full access to AS interventions) to satellites (hospitals without such access). METHODS: IMPULSE enhanced is a European, observational, prospective registry enrolling consecutive patients with newly diagnosed severe AS at four HVCs and 10 satellites. Clinical characteristics, interventions performed and outcomes up to 1 year by site-type were examined. RESULTS: Among 790 patients, 594 were recruited in HVCs and 196 in satellites. At baseline, patients in HVCs had more severe valve disease (higher peak aortic velocity (4.3 vs 4.1 m/s; p=0.008)) and greater comorbidity (coronary artery disease (CAD) (44% vs 27%; p<0.001) prior myocardial infarction (MI) (11% vs 5.1%; p=0.011) and chronic pulmonary disease (17% vs 8.9%; p=0.007)) than those presenting in satellites. An aortic valve replacement was performed more often by month 3 in HVCs than satellites in the overall population (52.6% of vs 31.3%; p<0.001) and in symptomatic patients (66.7% vs 43.2%, p<0.001). One-year survival rate was higher for patients in HVCs than satellites (HR2.19; 95% CI 1.28 to 3.73 total population and 2.89 (95%CI 1.64 to 5.11) for symptomatic patients. CONCLUSIONS: Our data support the implementation of referral pathways that direct patients to HVCs performing both surgery and transcatheter interventions. TRIAL REGISTRATION NUMBER: NCT03112629.
650    _2
$a lidé $7 D006801
650    12
$a transkatetrální implantace aortální chlopně $x škodlivé účinky $7 D065467
650    12
$a aortální stenóza $x diagnóza $x chirurgie $x komplikace $7 D001024
650    _2
$a centra sekundární péče $7 D063728
650    _2
$a výsledek terapie $7 D016896
650    _2
$a aortální chlopeň $x diagnostické zobrazování $x chirurgie $7 D001021
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Messika-Zeitoun, David $u Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada $1 https://orcid.org/0000000262785670
700    1_
$a Frey, Norbert $u Department of Cardiology and Angiology, University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Schleswig-Holstein, Germany $u Department of Cardiology, Angiology and Pneumology, Heidelberg University, Heidelberg, Baden-Württemberg, Germany
700    1_
$a Lutz, Matthias $u Department of Cardiology and Angiology, University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Schleswig-Holstein, Germany
700    1_
$a Krapf, Laura $u Department of Cardiology, Hospital Max Fourestier, Nanterre, Île-de-France, France
700    1_
$a Passefort, Stephanie $u Department of Cardiology, Hopital Andre Gregoire, Montreuil, Île-de-France, France
700    1_
$a Fryearson, John $u Department of Cardiology, South Warwickshire NHS Foundation Trust, Warwick, Warwickshire, UK
700    1_
$a Simpson, Helen $u Birmingham Heartlands Hospital, Birmingham, West Midlands, UK
700    1_
$a Mortensen, Kai $u Kardiologische Gemeinschaftspraxis Kiel, Kiel, Germany
700    1_
$a Rehse, Sebastian $u Departmet of Internal Medicine, Klinik Preetz, Preetz, Germany
700    1_
$a Tiroke, Andreas $u Praxis für Kardiologie, Kiel, Germany
700    1_
$a Dodos, Fotini $u Praxis für Innere Medizin, Kardiologie, Pneumologie am Wiener Platz, Vienna, Austria
700    1_
$a Mies, Florian $u Kardiologische Gemeinschaftspraxis Hohenlind, Cologne, Germany
700    1_
$a Deutsch, Cornelia $u 1Institute for Pharmacology and Preventive Medicine, IPPMed, Cloppenburg, Germany
700    1_
$a Kurucova, Jana $u Edwards Lifesciences AG Czech Republic Branch, Prague, Czech Republic
700    1_
$a Thoenes, Martin $u Edwards Lifesciences, Nyon, Switzerland
700    1_
$a Bramlage, Peter $u 1Institute for Pharmacology and Preventive Medicine, IPPMed, Cloppenburg, Germany $1 https://orcid.org/0000000349702110
700    1_
$a Steeds, Richard Paul $u Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, UK rick.steeds@uhb.nhs.uk
710    2_
$a IMPULSE enhanced investigators
773    0_
$w MED00002003 $t Heart (British Cardiac Society) $x 1468-201X $g Roč. 109, č. 12 (2023), s. 944-950
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36657962 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133013 $b ABA008
999    __
$a ok $b bmc $g 1963662 $s 1197639
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 109 $c 12 $d 944-950 $e 20230526 $i 1468-201X $m Heart $n Heart $x MED00002003
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace